- Physician-led plan
- Dose reviewed every block
- Weekly GLP-1 pen
- Weight Loss & Metabolism
- Entry tier
- Fixed price
- 12-week blocks, ongoing
Metabolic
GLP-1 agonist (semaglutide / tirzepatide) · AOD-9604 15 mg pen · MOTS-c 40 mg pen
GLP-1 medication for weight loss, paired with MOTS-c, a peptide your mitochondria make. Designed to help you lose weight while keeping your energy and muscle.
FromAED 10/ month
Order summary
- Subscribe & save
- [PRICE]
- At-home blood tests
- + [PRICE]
- Total
- [PRICE]
Prescription only. Your BioMax physician confirms the protocol is right for you on the call, and sets and adjusts every dose.
Overview
The entry-level medical weight-loss stack. A GLP-1 agonist does the heavy lifting on appetite and glycaemic control; AOD-9604 adds direct lipolysis without touching GH or IGF-1; and MOTS-c improves insulin sensitivity and mitochondrial fat oxidation. The three act on different pathways, so the combination targets appetite, fat breakdown and fat utilisation at the same time.
What's inside
GLP-1 agonist (semaglutide / tirzepatide)
Pre-filled pen- Dose
- As prescribed per BioMax GLP-1 titration protocol
- How
- Weekly pen
- Length
- Ongoing, reviewed every 12 weeks
AOD-9604 15 mg pen
Pre-filled pen- Dose
- 10 units (500 mcg) SQ once daily, morning on an empty stomach; no calories for 2–4 hours
MOTS-c 40 mg pen
Pre-filled pen- Dose
- 38 units (5 mg) SQ twice weekly (e.g. Mon & Thu), morning on an empty stomach, 4–8 week cycles, 2–4 weeks off
- How
- Pen
- Length
- Weeks 1–8, then weeks 9–12 off
Per Revitalize protocol. Units are insulin-pen units on the Revitalize pen. Dosing is indicative only. Every prescription is issued by a DHA-licensed physician after consultation and is individualised to the patient.
Your 12 weeks
Each block runs 12 weeks, with a review call at the end. MOTS-c restarts at the start of every new block.
GLP-1 runs in weeks 1 to 12, with the dose stepped up at each review. MOTS-c runs in weeks 1 to 8, with a break in weeks 9 to 12. Optional NAD+ runs in weeks 1 to 12. There is a dose review before month 2, and a review call at the end of week 12, then the next block begins.
What the research looks at
What researchers have measured so far. These are findings from studies, not promises of results.
Insulin sensitivity
In the original 2015 study, mice on a high-fat diet given MOTS-c were protected from weight gain and insulin resistance.
Fuel use
By activating AMPK, MOTS-c helps muscle take up sugar from the blood and burn fat for energy while protecting lean muscle, according to animal research.
Mitochondrial health
Research suggests MOTS-c may support the production of new mitochondria. Human studies are still at an early stage.
Cellular energy
NAD+ is central to how mitochondria produce ATP, and topping it up may help support steadier energy levels.
Who shouldn't use it
- Contraindicated in cancer, pregnancy/breastfeeding, under-18s
- MOTS-c: avoid in severe liver/kidney disease, autoimmune disorders, and with insulin or oral hypoglycaemics (additive hypoglycaemia risk)
GLP-1 is only prescribed when your physician agrees it is medically appropriate.
Your physician reviews your health history on the call before anything is prescribed.
FAQ
GLP-1s are only prescribed when medically appropriate. Your physician assesses this on the call, sets your starting dose and steps it up at each review.
Also in Weight Loss & Metabolism
Coming soon: Body Composition, Sexual Health and Skin & Hair
Not sure which protocol fits you?
A short assessment and a call with a DHA-licensed doctor.